Phase I Clinical Study of GNC-038 in Patients With Non-Hodgkin's Lymphoma or Acute Lymphoblastic Leukemia | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Phase I Clinical Study of GNC-038 in Patients With Non-Hodgkin's Lymphoma or Acute Lymphoblastic Leukemia	Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Precursor Cell Lymphoblastic Leukemia-Lymphoma, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoma, lymphoproliferative syndrome, neoplasm, non-Hodgkin lymphoma	Active, not recruiting	Phase 1	2025-09-26		NCT04606433

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Sichuan Baili Pharmaceutical Co., Ltd.	135
SystImmune Inc.	24

10 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Chongqing University Cancer Hospital	Chongqing	China	33
Guangdong Provincial People's Hospital	Guangzhou	China	59
Hematology Hospital, Chinese Academy of Medical Sciences	Tianjin	China	1
NanFang Hospital of Southern Medical University	Guangzhou	China	10
Peking University Third Hospital	Beijing	China	38
Shanghai Tongji Hospital	Shanghai	China	7
The First Affiliated Hospital of Chongqing Medical University	Chongqing	China	38
The Second Affiliated Hospital Zhejiang University School of Medicine	Hangzhou	China	22
The Second Hospital of Anhui Medical University	Hefei	China	21
Xiangya Hospital Central South University	Changsha	China	27